Design considerations for early-phase clinical trials of immune-oncology agents

di Wages, Nolan A., Chiuzan, Cody, Panageas, Katherine S.
Pubblicato in J Immunother Cancer (2018)

An adaptive dose-finding design based on both safety and immunologic responses in cancer clinical trials

di Chiuzan, Cody, Garrett-Mayer, Elizabeth, Nishimura, Michael
Pubblicato in Stat Biopharm Res (2018)

Survival of melanoma patients with brain metastases treated with ipilimumab and stereotactic radiosurgery

di Tazi, Karim, Hathaway, Amanda, Chiuzan, Cody, Shirai, Keisuke
Pubblicato in Cancer Med (2015)

A likelihood-based approach for computing the operating characteristics of the 3+3 phase I clinical trial design with extensions to other A+B designs

di Chiuzan, Cody, Garrett-Mayer, Elizabeth, Yeatts, Sharon D
Pubblicato in Clin Trials (2014)

Is more better? An analysis of toxicity and response outcomes from dose-finding clinical trials in cancer

di Brock, Kristian, Homer, Victoria, Soul, Gurjinder, Potter, Claire, Chiuzan, Cody, Lee, Shing
Pubblicato in BMC Cancer (2021)

Assessing drug use during follow-up: direct comparison of candidate outcome definitions in pooled analyses of addiction treatment studies

di Korte, Jeffrey E., Magruder, Kathy M., Chiuzan, Cody, Logan, Sarah, Killeen, Therese, Bandyopadhyay, Dipankar, Brady, Kathleen T.
Pubblicazione 2011

Impact of Depressive Symptoms on Future Alcohol Use in Patients with Co-occurring Bipolar Disorder and Alcohol Dependence: A Prospective Analysis in an 8-Week Randomized Controlled...

di Prisciandaro, James J., DeSantis, Stacia M., Chiuzan, Cody, Brown, Delisa G., Brady, Kathleen T., Tolliver, Bryan K.
Pubblicazione 2011

Dose-finding designs for trials of molecularly targeted agents and immunotherapies

di Chiuzan, Cody, Shtaynberger, Jonathan, Manji, Gulam A., Duong, Jimmy K., Schwartz, Gary K., Ivanova, Anastasia, Lee, Shing M.
Pubblicato in J Biopharm Stat (2017)

G-CSF/anti-G-CSF antibody complexes drive the potent recovery and expansion of CD11b(+)Gr-1(+) myeloid cells without compromising CD8(+) T cell immune responses

di Rubinstein, Mark P, Salem, Mohamed L, Doedens, Andrew L, Moore, Caitlin J, Chiuzan, Cody, Rivell, Guillermo L, Cole, David J, Goldrath, Ananda W
Pubblicazione 2013